Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Concurrent use of antiulcerative agents

J Monette1, H Mogun, R L Bohn

  • 1Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Journal of Clinical Gastroenterology
|June 1, 1997
PubMed
Summary

Many physicians prescribe multiple antiulcerative agents (AUAs) without evidence, leading to significant excess costs. This study identified patient factors predicting concurrent AUA use and estimated substantial financial burdens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Surgery Forum.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Trends in use of hydroxychloroquine during pregnancy in systemic lupus erythematosus patients from 2001 to 2015.

Lupus·2018
Same author

Are risk evaluation and mitigation strategies associated with less off-label use of medications? The case of immune thrombocytopenia.

Clinical pharmacology and therapeutics·2015
Same author

Patterns of treatment among a cohort of older low-income adults starting new medications for osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2014
Same author

An update on a systematic review of the use of geriatric assessment for older adults in oncology.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Outpatient calcium-channel blockers and the risk of postpartum haemorrhage: a cohort study.

BJOG : an international journal of obstetrics and gynaecology·2013

Area of Science:

  • Pharmacoeconomics
  • Gastroenterology
  • Health Services Research

Background:

  • Physicians frequently prescribe multiple antiulcerative agents (AUAs) concurrently.
  • Evidence supporting the efficacy of using more than one AUA simultaneously is limited.
  • This practice may lead to unnecessary costs and potential side effects.

Purpose of the Study:

  • To identify patient characteristics associated with concurrent AUA use.
  • To estimate the additional healthcare expenditures resulting from prescribing multiple AUAs instead of a single agent.

Main Methods:

  • A case-control study was conducted using New Jersey Medicaid enrollees aged 65 years and older.
  • Concurrent AUA use was defined conservatively.
  • Logistic regression analysis identified predictors of concurrent AUA use.

Related Experiment Videos

  • Additional drug expenditures were measured to assess excess costs.
  • Main Results:

    • Approximately 6.6% of AUA users were prescribed multiple agents concurrently.
    • Predictors of concurrent AUA use included prior gastrointestinal procedures, NSAID use, nursing home residency, and prolonged hospitalization.
    • No association was found with age, sex, or number of pharmacies used.
    • The estimated excess cost per patient for a second AUA ranged from $151 to $210 over 180 days, translating to $301-$420 annually.
    • National annual excess costs for the elderly population were estimated between $457 million and $637 million.

    Conclusions:

    • Concurrent use of multiple antiulcerative agents is common despite a lack of supporting evidence for increased efficacy.
    • This practice incurs substantial excess costs and potential risks without additional therapeutic benefit.
    • Reducing duplicative AUA prescribing could lead to significant healthcare savings.